|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online February 18, 2004
doi: 10.1242/10.1242/dev.01022
1 Rudolf Magnus Institute of Neuroscience, Department of Pharmacology and
Anatomy, University Medical Center, Universiteitsweg 100, 3584 CG Utrecht, The
Netherlands
2 GSF, Institute of Developmental Genetics, Ingolstaedter Landstrasse 1, D-85764
München, Germany
* Author for correspondence (e-mail: m.p.smidt{at}med.uu.nl)
Accepted 28 November 2003
The mesencephalic dopamine (mesDA) system is involved in the control of movement and behavior. The expression of Pitx3 in the brain is restricted to the mesDA system and the gene is induced relatively late, at E11.5, a time when tyrosine hydroxylase (Th) gene expression is initiated. We show here that, in the Pitx3-deficient aphakia (ak) mouse mutant, the mesDA system is malformed. Owing to the developmental failure of mesDA neurons in the lateral field of the midbrain, mesDA neurons are not found in the SNc and the projections to the caudate putamen are selectively lost. However, Pitx3 is expressed in all mesDA neurons in control animals. Therefore, mesDA neurons react specifically to the loss of Pitx3. Defects of motor control where not seen in the ak mice, suggesting that other neuronal systems compensate for the absence of the nigrostriatal pathway. However, an overall lower activity was observed. The results suggest that Pitx3 is specifically required for the formation of the SNc subfield at the onset of dopaminergic neuron differentiation.
Key words: Mesencephalic, Dopaminergic, Pitx3, Substantia nigra
This article has been cited by other articles:
![]() |
D. Omodei, D. Acampora, P. Mancuso, N. Prakash, L. G. Di Giovannantonio, W. Wurst, and A. Simeone Anterior-posterior graded response to Otx2 controls proliferation and differentiation of dopaminergic progenitors in the ventral mesencephalon Development, October 15, 2008; 135(20): 3459 - 3470. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Roussa, O. Oehlke, B. Rahhal, S. Heermann, S. Heidrich, M. Wiehle, and K. Krieglstein Transforming Growth Factor {beta} Cooperates with Persephin for Dopaminergic Phenotype Induction Stem Cells, July 1, 2008; 26(7): 1683 - 1694. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hedlund, J. Pruszak, T. Lardaro, W. Ludwig, A. Vinuela, K.-S. Kim, and O. Isacson Embryonic Stem Cell-Derived Pitx3-Enhanced Green Fluorescent Protein Midbrain Dopamine Neurons Survive Enrichment by Fluorescence-Activated Cell Sorting and Function in an Animal Model of Parkinson's Disease Stem Cells, June 1, 2008; 26(6): 1526 - 1536. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Roybon, T. Hjalt, N. S. Christophersen, J.-Y. Li, and P. Brundin Effects on Differentiation of Embryonic Ventral Midbrain Progenitors by Lmx1a, Msx1, Ngn2, and Pitx3 J. Neurosci., April 2, 2008; 28(14): 3644 - 3656. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. O'Keeffe, S. A. Scott, P. Tyers, G. W. O'Keeffe, J. W. Dalley, R. Zufferey, and M. A. Caldwell Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease Brain, March 1, 2008; 131(3): 630 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Coulon, A. L'Honore, J.-F. Ouimette, E. Dumontier, P. van den Munckhof, and J. Drouin A Muscle-specific Promoter Directs Pitx3 Gene Expression in Skeletal Muscle Cells J. Biol. Chem., November 9, 2007; 282(45): 33192 - 33200. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. J. Jacobs, S. M. Smits, C. W. Noorlander, L. von Oerthel, A. J. A. van der Linden, J. P. H. Burbach, and M. P. Smidt Retinoic acid counteracts developmental defects in the substantia nigra caused by Pitx3 deficiency Development, July 15, 2007; 134(14): 2673 - 2684. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sonnier, G. Le Pen, A. Hartmann, J.-C. Bizot, F. Trovero, M.-O. Krebs, and A. Prochiantz Progressive Loss of Dopaminergic Neurons in the Ventral Midbrain of Adult Mice Heterozygote for Engrailed1 J. Neurosci., January 31, 2007; 27(5): 1063 - 1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sgado, L. Alberi, D. Gherbassi, S. L. Galasso, G. M. J. Ramakers, K. N. Alavian, M. P. Smidt, R. H. Dyck, and H. H. Simon Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice PNAS, October 10, 2006; 103(41): 15242 - 15247. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Rover, J. C. Lodder, M. P. Smidt, and A. B. Brussaard Pitx3 Deficiency in Mice Affects Cholinergic Modulation of GABAergic Synapses in the Nucleus Accumbens J Neurophysiol, October 1, 2006; 96(4): 2034 - 2041. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-L. Ang Transcriptional control of midbrain dopaminergic neuron development Development, September 15, 2006; 133(18): 3499 - 3506. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. J. Jacobs, S. M. Smits, K. J. M. Hornman, J. P. H. Burbach, and M. P. Smidt Strategies to unravel molecular codes essential for the development of meso-diencephalic dopaminergic neurons J. Physiol., September 1, 2006; 575(2): 397 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Roussa, M. Wiehle, N. Dunker, S. Becker-Katins, O. Oehlke, and K. Krieglstein Transforming Growth Factor {beta} Is Required for Differentiation of Mouse Mesencephalic Progenitors into Dopaminergic Neurons In Vitro and In Vivo: Ectopic Induction in Dorsal Mesencephalon Stem Cells, September 1, 2006; 24(9): 2120 - 2129. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Griesel, D. Treichel, P. Collombat, J. Krull, A. Zembrzycki, W. M. R. van den Akker, P. Gruss, A. Simeone, and A. Mansouri Sp8 controls the anteroposterior patterning at the midbrain-hindbrain border Development, May 1, 2006; 133(9): 1779 - 1787. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bidinost, M. Matsumoto, D. Chung, N. Salem, K. Zhang, D. W. Stockton, A. Khoury, A. Megarbane, B. A. Bejjani, and E. I. Traboulsi Heterozygous and Homozygous Mutations in PITX3 in a Large Lebanese Family with Posterior Polar Cataracts and Neurodevelopmental Abnormalities. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1274 - 1280. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Martinat, J.-J. Bacci, T. Leete, J. Kim, W. B. Vanti, A. H. Newman, J. H. Cha, U. Gether, H. Wang, and A. Abeliovich Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype PNAS, February 21, 2006; 103(8): 2874 - 2879. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kele, N. Simplicio, A. L. M. Ferri, H. Mira, F. Guillemot, E. Arenas, and S.-L. Ang Neurogenin 2 is required for the development of ventral midbrain dopaminergic neurons Development, February 1, 2006; 133(3): 495 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Andersson, J. B. Jensen, M. Parmar, F. Guillemot, and A. Bjorklund Development of the mesencephalic dopaminergic neuron system is compromised in the absence of neurogenin 2 Development, February 1, 2006; 133(3): 507 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Prakash, C. Brodski, T. Naserke, E. Puelles, R. Gogoi, A. Hall, M. Panhuysen, D. Echevarria, L. Sussel, D. M. V. Weisenhorn, et al. A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo Development, January 1, 2006; 133(1): 89 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yan, D. Yang, E. D. Zarnowska, Z. Du, B. Werbel, C. Valliere, R. A. Pearce, J. A. Thomson, and S.-C. Zhang Directed Differentiation of Dopaminergic Neuronal Subtypes from Human Embryonic Stem Cells Stem Cells, June 1, 2005; 23(6): 781 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-Y. Hwang, S. M. Fleming, P. Ardayfio, T. Moran-Gates, H. Kim, F. I. Tarazi, M.-F. Chesselet, and K.-S. Kim 3,4-Dihydroxyphenylalanine Reverses the Motor Deficits in Pitx3-Deficient Aphakia Mice: Behavioral Characterization of a Novel Genetic Model of Parkinson's Disease J. Neurosci., February 23, 2005; 25(8): 2132 - 2137. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Alberi, P. Sgado, and H. H. Simon Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons Development, July 1, 2004; 131(13): 3229 - 3236. [Abstract] [Full Text] [PDF] |
||||